Aquarius Biotechnologies is categorized under Commercial Biotechnical Research in Chicago, IL and active since 2012.
Aquarius Biotechnologies was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Donnie Phillips at the company’s single location by writing to 2037 West Carroll Avenue, Chicago, Illinois IL 60612 or by phoning (908) 399-1553. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Aquarius Biotechnologies |
| Contact Person: | Donnie Phillips |
| Address: | 2037 West Carroll Avenue, Chicago, Illinois 60612 |
| Phone Number: | (908) 399-1553 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Aquarius Biotechnologies was started in 2012 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Donnie Phillips for inquiries that concern Aquarius Biotechnologies by calling the company number (908) 399-1553, as your correspondence is most welcome. Additionally, the physical location of the single location of Aquarius Biotechnologies can be found at the coordinates 41.887518,-87.678025 as well as the street address 2037 West Carroll Avenue in Chicago, Illinois 60612.
For its online presence, you may visit Aquarius Biotechnologies’s website at and engage with its social media outlets through on Twitter and on Facebook.